Financials
- Market Capitalization 5.8 B
- Employee 370
- Founded 1996
- CEO N/A
- Website www.xenon-pharma.com
- Headquarter British Columbia, Canada
- FIGI BBG0073DM784
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.28
Rapporto prezzo/fatturato
473.62
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1227 | BLTE Belite Bio Inc - American Depositary Shares | 152.22 USD | -3.05% | -5.44% | -0.65% | +138.59% | 5.99 B USD | ||
| 1228 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 107.05 USD | -4.03% | -3.98% | +4.83% | +332.70% | 5.99 B USD | ||
| 1249 | PTCT PTC Therapeutics, Inc. - Common Stock | 70.04 USD | -2.46% | -0.64% | -6.43% | +40.59% | 5.85 B USD | ||
| 1266 | DFTX Definium Therapeutics, Inc. - Common Shares | 41.51 USD | -5.27% | -8.41% | -1.17% | +174.72% | 5.58 B USD |